Secured Creditors Approve Amalgamation Scheme with Dr. Agarwal's Eye Hospital

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹476.00

prior close

₹479.00

announcement price

After-mkt

timing

Nifty Microcap 250market-0.3%+0.4% vs market

Hospital peers, median of 23sector+0.4%-0.3% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.2

15m

-0.4

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1-0.3+0.4+0.4-0.3

Next day

+0.6-0.1+0.8-0.1+0.7

-1.3-0.8-0.4-0.4-0.9

+0.4-2.8+3.3-2.9+3.3

+1.9-1.0+2.9-0.6+2.5

+0.6+0.4+0.2-0.7+1.3

+2.3-0.5+2.8-1.6+3.9

15d

+1.2-1.9+3.1-2.0+3.2

+1.3+0.4+0.8-1.9+3.1

+7.2+3.5+3.7-1.2+8.4

+1.6+2.0-0.4-9.4+11.0

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Agarwal's Health Care informed that at the NCLT-convened meeting of secured creditors held on July 2, 2026 in Chennai, the amalgamation scheme with Dr. Agarwal's Eye Hospital (transferor) was approved. All 3 secured creditors, representing a total voting value of about Rs 73.83 crore, voted 100% in favour. The scheme still requires NCLT sanction and other regulatory approvals.

Likely market impact

Positive progress on the amalgamation. Still awaits NCLT sanction and other approvals before the scheme becomes effective.